Pharmaceutical Practices And Patient Outcomes
88 researchers across 8 institutions
Researchers in pharmaceutical practices and patient outcomes investigate how medications are used in real-world settings and the subsequent effects on patient health. This area examines medication safety, effectiveness, and adherence, employing diverse methodologies such as clinical trials, observational studies, and health services research. Key sub-fields include pharmacoeconomics, which assesses the value of pharmaceutical interventions; pharmacovigilance, focused on drug safety monitoring and adverse event reporting; and pharmacoepidemiology, which studies drug use and outcomes in large populations. Investigations also explore the optimization of medication therapy management services and the impact of health policies on pharmaceutical access and utilization.
This research holds particular relevance for Arkansas, a state with significant rural populations and a high burden of chronic diseases. Studies can inform strategies to improve medication access and adherence in underserved communities, address health disparities related to pharmaceutical care, and evaluate the economic impact of drug therapies on the state's healthcare system. Understanding how Arkansans utilize and respond to medications is crucial for developing targeted public health interventions and optimizing healthcare delivery across diverse demographic groups within the state.
This research area benefits from strong interdisciplinary connections with healthcare policy, health sciences, and public health. Engagement spans multiple Arkansas institutions, fostering a comprehensive approach to understanding and improving pharmaceutical practices and patient outcomes statewide.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| Christopher Johnson | UAMS | 50 | 14,110 | ||
| Aleda M.H. Chen | UAMS | 27 | 2,300 | High Impact | |
| Jacob T. Painter | UAMS | 22 | 1,607 | High Impact | |
| Holly Maples | UAMS | 20 | 2,795 | High Impact | |
| Rebecca J. Bartlett Ellis | University of Arkansas | 19 | 1,539 | ||
| James Thrasher | UAMS | 18 | 5,139 | ||
| Ellen Jones | Harding University Main Campus | 16 | 1,206 | ||
| Landry K. Kamdem | Harding University Main Campus | 14 | 1,167 | ||
| Heather Black | UA Little Rock | 12 | 472 | ||
| Sandy Johnson | University of Arkansas – Fort Smith | 12 | 1,028 | ||
| Megan G. Smith | UAMS | 10 | 481 | ||
| Chris Johnson | UAMS | 10 | 446 | ||
| Denise Ragland | UAMS | 10 | 398 | ||
| Laura E. Gressler | UAMS | 9 | 383 | ||
| Jill Johnson | UAMS | 9 | 207 | ||
| Maraya Camazine | UAMS | 9 | 627 | ||
| Lindsey Dayer | UAMS | 9 | 766 | ||
| H. Williams | UAMS | 8 | 498 | ||
| Nikhil Singh | University of Arkansas – Fort Smith | 7 | 375 | ||
| Carlos M. Wells | NCTR | 6 | 423 |
Related Research Areas
Connected Research Areas
Topics that share active collaborators with Pharmaceutical Practices And Patient Outcomes in Arkansas. Pairs are ranked by collaboration density relative to expected co-authorship under a random null. This describes existing connections, not investment recommendations.
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 University of North Carolina at Chapel Hill 1,237
- 2 Harvard University 1,104
- 3 University of Michigan 890
- 4 Brigham and Women's Hospital 859
- 5 Johns Hopkins University 833
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Pharmaceutical Practices And Patient Outcomes.